Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Lecumberri, M. J."'
Autor:
Verdún, Juan Antonio, Puértolas, T. J., Corral, Mónica, Lecumberri, M. J., Gálvez Buerba, Eva Mª, Pardo, Julián, Antón Torres, A.
Publikováno v:
Digital.CSIC. Repositorio Institucional del CSIC
instname
instname
of the poster presented at the III Symposium Immunotherapy Cancer, held in Zaragoza, November 7th 2019.
[Background]: Uveal melanoma (UM) is a rare entity that arises from melanocytes in the uveal tract; although littlehas in common with cutaneo
[Background]: Uveal melanoma (UM) is a rare entity that arises from melanocytes in the uveal tract; although littlehas in common with cutaneo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::9a097ce406e585a8481f0664091bcb80
http://hdl.handle.net/10261/254438
http://hdl.handle.net/10261/254438
Autor:
Martinez-Trufero, J., Isla, D., Adansa, J. C., Irigoyen, A., Hitt, R., Gil-Arnaiz, I., Lambea, J., Lecumberri, M. J., Cruz, J. J.
Publikováno v:
British Journal of Cancer; 6/8/2010, Vol. 102 Issue 12, p1687-1691, 5p, 2 Charts, 2 Graphs
Autor:
R. D. de Beveridge, A. Estival, Isabel Sevilla, J. Rubió, Virginia Martínez, D. Vicente, César Serrano, Andres Poveda, Javier Martin-Broto, M. J. Lecumberri
Publikováno v:
CLINICAL & TRANSLATIONAL ONCOLOGY
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Digital.CSIC. Repositorio Institucional del CSIC
Clinical & Translational Oncology
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Digital.CSIC. Repositorio Institucional del CSIC
Clinical & Translational Oncology
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal neoplasms of the digestive tract, and this disease has served as a paradigmatic model for successful rational development of targeted therapies. The introduction of tyrosine kina
Autor:
Poveda A; Department of Medical Oncology, Instituto Valenciano de Oncología, IVO, Valencia, Spain., Martinez V; Department of Medical Oncology, Hospital Universitario La Paz, Madrid, Spain., Serrano C; Department of Medical Oncology, Vall d'Hebron Institute of Oncology, Hospital Universitario Vall d'Hebron, Barcelona, Spain., Sevilla I; Investigación Clínica y Traslacional en Cáncer, Instituto de Investigaciones Biomédicas de Málaga (IBIMA), Hospitales Universitarios Regional y Virgen de la Victoria de Málaga, Málaga, Spain., Lecumberri MJ; Department of Medical Oncology, Complejo Hospitalario de Navarra, Navarre, Spain., de Beveridge RD; Musculoskeletal and Gastric Tumor Unit, Department of Medical Oncology, Hospital Universitario y Politécnico La Fe, Valencia, Spain., Estival A; Department of Medical Oncology, Instituto Catalán de Oncología, ICO-Badalona, Hospital Germans Trias i Pujol, Badalona, Spain., Vicente D; Department of Medical Oncology, Hospital Universitario Virgen Macarena, Badalona, Spain., Rubió J; Department of Medical Oncology, Instituto Catalán de Oncología, ICO-Girona, Hospital Josep Trueta, Girona, Spain., Martin-Broto J; Department of Medical Oncology and Insituto de Biomedicina, IBIS, Hospital Universitario Virgen del Rocio, Av. Manuel Siurot, s/n, 41013, Sevilla, Spain. jmartin@mustbesevilla.org.
Publikováno v:
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico [Clin Transl Oncol] 2016 Dec; Vol. 18 (12), pp. 1221-1228. Date of Electronic Publication: 2016 Nov 28.